Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 09:55 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | MS | 43 beds | Grade C | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 253027 | HARRISON, MS | 43 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 43-bed suburban community hospital in HARRISON, MS with $27.7M in net patient revenue and a 29.9% operating margin. The hospital serves a payer mix of 73.9% Medicare, 4.2% Medicaid, and 21.9% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 29.9% to 37.2% (+736bps).

Net Revenue HCRIS$27.7M
Current EBITDA COMPUTED$8.3M
Operating Margin COMPUTED29.9%
Occupancy HCRIS99.3%
Revenue / Bed COMPUTED$644K
Net-to-Gross HCRIS67.3%
Distress Probability ML43.5%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
63
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 29.9% places it above the state median. Among 63 size-comparable peers (22-86 beds), the median margin is -13.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-86), prioritizing same-state peers. 63 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)MS43$27.7M29.9%
BAPTIST MEM HOSPITAL UNION COUMS83$117.9M3.7%
KINGS DAUGHTERS MEDICAL CENTERMS22$91.5M-8.4%
METHODIST H/C OLIVE BRANCH HOSMS65$75.4M-25.6%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
UMMC-GRENADAMS49$63.7M7.1%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
ALLIANCE HEALTH CENTERMS79$46.1M32.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$581K+210bp18mo
Cost to Collect4.5%2.5%$553K+200bp12mo
Denial Rate Reduction12.0%6.5%$548K+198bp12mo
A/R Days Reduction5200.0%3800.0%$337K+122bp9mo
Clean Claim Rate88.0%96.0%$18K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$581K
Cost to Collect
$553K
Denial Rate Reduction
$548K
A/R Days Reduction
$337K
Clean Claim Rate
$18K
Total EBITDA Uplift$2.0M
Current EBITDA$8.3M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$10.3M
Current Margin29.9%
Pro Forma Margin37.2%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$12.7M$74.9M5.89x42.6%
Base (11x exit)10.0x11.0x$12.7M$86.5M6.80x46.7%
Bull Case9.0x11.0x$11.5M$97.4M8.51x53.4%
Bull (12x exit)9.0x12.0x$11.5M$109.6M9.57x57.1%
Bear Case11.0x10.0x$14.0M$60.6M4.33x34.1%
Bear (11x exit)11.0x11.0x$14.0M$71.2M5.09x38.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 73.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 63 hospitals with 22-86 beds
  • Same-state prioritization (n=64)
  • Comp margins: P25=-22.6% / P50=-13.9% / P75=-1.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.